- Pfizer (New York, NY)
- …heterogeneity can be used to encourage and guide shared clinical decision making. The Patient Preference Evidence Generation is responsible developing ... providers, and policy makers, among others. The PPEG for IM/I&I will oversee patient preference evidence generation activities and ensure excellence in… more
- Sanofi Group (Morristown, NJ)
- …Target Product Profiles (TPP) and Target Product Label (TPL) linked to associated evidence generation , notably a differentiated COA strategy. + Main point of ... of experience. As needed, anticipate, coordinate and execute on patient preference modelling and studies. + Health...with interactions with regulators and payers. + Experience with evidence generation beyond RCT: eg, integration and… more